Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in SCLX — Scilex Holding Co

CIK 1115418 BOSTON, MA
Back to SCLX Full portfolio

Position in SCLX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$273
+$40 QoQ
Shares Held
35
-37.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 72 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 14% Shared 0% None 86%

Common Shares in SCLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $4,800,494,597 across 17 Drug Manufacturers - General names. SCLX ranks #17 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 1,333,307 $1,599,208,548
2 JNJ
Johnson & Johnson
 3,780,752 $960,197,585
3 ABBV
AbbVie Inc.
 2,733,648 $687,895,182
4 MRK
Merck & Co., Inc.
 3,809,518 $489,523,063
5 AMGN
Amgen Inc
 904,954 $327,701,942
6 GILD
Gilead Sciences, Inc.
 2,051,819 $259,226,812
7 PFE
Pfizer Inc
 8,609,603 $207,319,240
8 BMY
Bristol Myers Squibb Co
 3,347,347 $192,874,134

All Filings in SCLX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $273 35
2026-03-31 $233 35
2025-12-31 $426 35
2025-09-30 $688 35
2025-06-30 $223 38
2025-03-31 $19,437 78,063
2024-12-31 $36,147 84,853
2024-09-30 $78,489 84,853
2024-06-30 $162,517 84,206
2024-03-31 $137,449 86,446
2023-12-31 $176,349 86,446
2023-09-30 $121,024 86,446
2023-06-30 $481,504 86,446
2023-03-31 $700,599 85,439